Janika Blömeke
Janika Blömeke
M. Sc.
  • Research assistant
Working area


W26 , 2nd Floor
German (Mother tongue)



Psychometric performance of the Quality of Life in Short Stature Youth (QoLISSY) questionnaire in a randomized open-label comparator trial in idiopathic short stature
Bloemeke J, Balacano Valdez R, Mauras N, Mericq V, Ross J, Permuy J, Quitmann J, Bullinger M
J PEDIATR ENDOCRINOL METAB. 2019;32(10):1089-1101.

Psychometric properties of the quality of life in short statured youth (QoLISSY) questionnaire within the course of growth hormone treatment
Bloemeke J, Silva N, Bullinger M, Witt S, Dörr H, Quitmann J
HEALTH QUAL LIFE OUT. 2019;17(1):49.

Cross-cultural selection and validation of instruments to assess patient-reported outcomes in children and adolescents with achondroplasia
Bloemeke J, Sommer R, Witt S, Bullinger M, Nordon C, Badia F, González F, Leiva-Gea A, Delgado Rufino F, Mayoral-Cleries F, Romero-Sanchiz P, Clamagirand Saiz V, Nogueira-Arjona R, Mohnike K, Quitmann J
QUAL LIFE RES. 2019;28(9):2553-2563.

Piloting and psychometric properties of a patient-reported outcome instrument for young people with achondroplasia based on the International Classification of Functioning Disability and Health: the Achondroplasia Personal Life Experience Scale (APLES)
Bloemeke J, Sommer R, Witt S, Dabs M, Badia F, Bullinger M, Quitmann J
DISABIL REHABIL. 2019;41(15):1815-1825.

Quality of Life in Adolescent Boys with Idiopathic Short Stature: Positive Impact of Growth Hormone and Aromatase Inhibitors
Bullinger M, Bloemeke J, Mericq V, Sommer R, Gaete X, Ross J, Yu Y, Permuy J, Gagliardi P, Damaso Y, Mauras N
Horm Res Paediat. 2019 [Epub ahead of print];90(6):381-392.

First-year predictors of health-related quality of life changes in short-statured children treated with human growth hormone
Quitmann J, Bloemeke J, Dörr H, Bullinger M, Witt S, Silva N
J ENDOCRINOL INVEST. 2019;42(9):1067-1076.

Quality of Life of Short-Statured Children Born Small for Gestational Age or Idiopathic Growth Hormone Deficiency Within 1 Year of Growth Hormone Treatment
Quitmann J, Bloemeke J, Silva N, Bullinger M, Witt S, Akkurt I, Dunstheimer D, Vogel C, Böttcher V, Kuhnle Krahl U, Bettendorf M, Schönau E, Fricke-Otto S, Keller A, Mohnike K, Dörr H
FRONT PEDIATR. 2019;7:164.

Agreement between mothers', fathers', and children's' ratings on health-related quality of life in children born with esophageal atresia - a German cross-sectional study
Witt S, Bloemeke J, Bullinger M, Dingemann J, Dellenmark-Blom M, Quitmann J
BMC PEDIATR. 2019;19(1):330.

Quality of life of children with achondroplasia and their parents - a German cross-sectional study
Witt S, Kolb B, Bloemeke J, Mohnike K, Bullinger M, Quitmann J
ORPHANET J RARE DIS. 2019;14(1):194.


The psychometric evaluation of the quality of life in short stature youth (QoLISSY) instrument for German children born small for gestational age
Sommer R, Blömeke J, Bullinger M, Quitmann J
J ENDOCRINOL INVEST. 2018;41(10):1185-1191.

Adrenogenitales Syndrom (AGS) mit 21-Hydroxylase-Defekt bei Kleinkindern: Erste Ergebnisse einer Pilotstudie zur psychosozialen Situation der Eltern
Witt S, Blömeke J, Dörr H, Quitmann J
Päd Praxis. 2018;90(1):29-37.


An ICF-CY-based approach to assessing self- and observer-reported functioning in young persons with achondroplasia - development of the pilot version of the Achondroplasia Personal Life Experience Scale (APLES)
Sommer R, Blömeke J, Dabs M, Witt S, Bullinger M, Quitmann J
DISABIL REHABIL. 2017;39(24):2499-2503.

Letzte Aktualisierung aus dem FIS: 24.10.2020 - 06:56 Uhr